Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit Patients With Acute Myeloid Leukemia Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
Latest Information Update: 16 Jan 2024
At a glance
- Drugs Venetoclax (Primary) ; DNA methylation inhibitors
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 12 Dec 2023 Results (n=178) of an analysis reporting real world outcome of unfit patients with acute myeloid leukemia presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 16 Aug 2021 Status changed from not yet recruiting to recruiting.
- 23 Oct 2020 New trial record